Latest News in the pharma Industry

Market News

Recipharm delivers first serialised batch to Saudi Arabia

Recipharm delivers first serialised batch to Saudi Arabia

23 Apr 2017

Company has invested €300,000 into the project, which is part of a wider €40 million investment into new serialisation technology and processes to comply with the European Falsified Medicines Directive.

Read more 
Pfizer unveils ATLAS, an Interactive, website that provides global antibiotic resistance surveillance data across 60 countries

Pfizer unveils ATLAS, an Interactive, website that provides global antibiotic resistance surveillance data across 60 countries

23 Apr 2017

Website can help inform global health strategies to mitigate the threat of antimicrobial resistance.

Read more 
World’s largest society for regulatory professionals increases investment in Europe

World’s largest society for regulatory professionals increases investment in Europe

20 Apr 2017

An investment of more than 2 million euro over 3 years is planned to launch new events and resources.

Read more 
Merck partners with Drugs for Neglected Diseases initiative

Merck partners with Drugs for Neglected Diseases initiative

19 Apr 2017

Merck is opening its compound library to DNDi to help find cures for leishmaniasis and Chagas disease.

Read more 
Nivalis Therapeutics  and Alpine Immune Sciences agree to merge

Nivalis Therapeutics and Alpine Immune Sciences agree to merge

19 Apr 2017

Combined company well capitalized with $90 million in funding to advance discovery and development.

Read more 
Fujifilm increases production capacity and establishes new process development facilities

Fujifilm increases production capacity and establishes new process development facilities

19 Apr 2017

$130M USD investment to support growing market demand.

Read more 
Porvair acquires J.G. Finneran Associates

Porvair acquires J.G. Finneran Associates

19 Apr 2017

Finneran bringing glass, plastics and assembly manufacturing capabilities and strong US distribution.

Read more 
Cardinal Health to acquire leading patient product portfolio from Medtronic for $6.1 billion

Cardinal Health to acquire leading patient product portfolio from Medtronic for $6.1 billion

18 Apr 2017

Increases Cardinal Health's product breadth in consumable medical products.

Read more 
Cobra Biologics embarks on £15 m gene therapy manufacturing operations expansion

Cobra Biologics embarks on £15 m gene therapy manufacturing operations expansion

18 Apr 2017

Capacity increase in response to customer demand for DNA and viral vector production.

Read more 
Allergan expands leading R&D NASH Program with Novartis Clinical Collaboration

Allergan expands leading R&D NASH Program with Novartis Clinical Collaboration

18 Apr 2017

Collaboration focused on Phase 2II clinical trial to evaluate use of Allergan's Cenicriviroc and Novartis' lead FXR agonist to treat NASH.

Read more 
BMS to license anti-eTau and anti-myostatic compounds

BMS to license anti-eTau and anti-myostatic compounds

16 Apr 2017

Two separate agreements with Biogen and Roche.

Read more 
Bosch launches new WFI system at interpack

Bosch launches new WFI system at interpack

12 Apr 2017

Efficient alternative to distillation.

Read more